Envestnet Portfolio Solutions Inc. Purchases 173,993 Shares of Axon Enterprise, Inc $AXON

23 Sep 2026, 19:38 by Jessica Moore · The Cerbat Gem

Envestnet Portfolio Solutions Inc. raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 16,200.5% in the second quarter, Holdings Channel reports. The fund owned 175,067 shares of the biotechnology company’s stock after buying an additional 173,993 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Axon Enterprise were worth $98,144,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pure Financial Advisors LLC lifted its position in shares of Axon Enterprise by 6.7% during the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after purchasing an additional 23 shares during the last quarter. Keel Point LLC boosted its stake in Axon Enterprise by 4.4% during the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock valued at $254,000 after purchasing an additional 25 shares during the period. Bridgewater Advisors Inc. grew its holdings in Axon Enterprise by 4.4% in the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after buying an additional 26 shares during the last quarter. Roman Butler Fullerton & Co. grew its holdings in Axon Enterprise by 2.4% in the 1st quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after buying an additional 30 shares during the last quarter. Finally, 44 Wealth Management LLC increased its position in Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock worth $225,000 after buying an additional 30 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Chattanooga’s city council renewed its contract with Axon for five years, reinforcing the company’s recurring public-sector revenue base and customer retention. Chattanooga City Council renews five-year contract with Axon Enterprise
Positive Sentiment: The Los Angeles Police Department approved a license-plate-reader pilot as a broader Axon technology agreement moves toward consideration by the city council. The pilot could create an opportunity for a larger contract, although approval is not yet certain. LAPD ALPR Pilot Approved as Axon Tech Deal Heads to City Council
Neutral Sentiment: Reports that AXON gained in premarket trading and during the Nasdaq session describe market performance rather than identifying a new fundamental catalyst. Axon Enterprise stock gains 1.61 percent on Nasdaq
Negative Sentiment: Axon and Flock executives did not attend a Senate hearing on surveillance technology after Chair Josh Hawley warned that subpoenas could be issued. The episode raises regulatory, political and reputational risks for Axon’s public-safety technology business. Flock, Axon dodge Senate hearing after invite from Chair Josh Hawley
Negative Sentiment: Recent commentary points to margin and debt concerns, while another analysis questions whether Axon’s valuation and growth justify choosing it over ServiceNow. These concerns are especially significant given AXON’s elevated earnings multiple and recent weakness. Axon Enterprise stock slips as margins and debt pressure sentiment

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey Kunins sold 9,605 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the sale, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This trade represents a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 67,397 shares of company stock worth $38,160,884. Insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the subject of a number of research analyst reports. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. The Goldman Sachs Group restated a “buy” rating and issued a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, September 2nd. Piper Sandler upped their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $721.57.

Get Our Latest Research Report on Axon Enterprise

Axon Enterprise Stock Performance

AXON stock traded down $8.71 during midday trading on Wednesday, hitting $450.61. The stock had a trading volume of 770,373 shares, compared to its average volume of 1,054,314. The firm has a market capitalization of $36.61 billion, a price-to-earnings ratio of 186.98, a P/E/G ratio of 8.51 and a beta of 1.40. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $789.29. The stock has a 50-day simple moving average of $543.84 and a 200 day simple moving average of $484.85. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the previous year, the firm posted $2.12 EPS. The business’s revenue for the quarter was up 35.3% on a year-over-year basis. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 2.12 earnings per share for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.